Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Advanced synthesis of chiral 5-(4-fluorophenyl)-5-hydroxypentanoate via lactone intermediate. High purity Ezetimibe intermediate with scalable, cost-effective manufacturing.
Novel patent CN105461671B enables cost-effective high-purity intermediate production with simplified supply chain and scalable manufacturing processes for global buyers.
Patent CN107663185A reveals a cost-effective titanium-zinc catalyzed route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Patent CN107663185A reveals a low-cost titanium-zinc catalytic route for high-purity butyrolactone derivatives, ensuring supply chain stability.
Novel titanium-zinc method for butyrolactone derivative ensures high purity and scalable supply chain for epilepsy drug intermediates globally.
Patent CN113754616A details a high-yield synthesis of trans-3-thiophenyl-gamma-lactone. Discover cost-effective manufacturing and supply chain advantages for flavor intermediates.
Advanced synthesis of optically pure 2-methyl alkyl glycol derivatives from lactones. Reliable supplier for pharma intermediates offering cost-effective, scalable chiral building blocks.
Efficient semi-synthesis of deserpidine from reserpine lactone via selective demethylation. Reduces costs and improves supply chain reliability for antihypertensive APIs.
Patent CN102190642B reveals a novel Prins reaction route for Corey lactone. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102190642A reveals a scalable Prins reaction route for high-purity Corey lactone, offering significant cost reduction in prostaglandin manufacturing.
Novel route for polycyclic lactones via Sonogashira coupling. Reduces cost in pharmaceutical intermediate manufacturing with high purity.
Patent CN117467631B reveals novel P450 mutant for gamma-lactone. Enables cost reduction in fine chemical manufacturing with high selectivity.
Patent CN110386942A reveals high-yield thiolactone synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel tetrapeptide-catalyzed asymmetric Aldol synthesis for high-purity pharmaceutical intermediates. Cost-effective route to pantolactone with superior enantioselectivity.
Patent CN111848320A reveals a tetrapeptide-catalyzed asymmetric Aldol route achieving 99% ee for pantolactone precursors, offering a scalable, metal-free solution for reliable pharmaceutical intermediate suppliers.
Patent CN108976123B details a Pd-catalyzed method for axial chiral allenes with 90-96% ee. Enables cost-effective synthesis of pharmaceutical intermediates and natural products like traumatic lactone.
Patent CN100548965C details scalable synthesis of optically pure omega-hydroxy acid derivatives from steroidal sapogenin waste, offering cost-effective chiral building blocks.
Novel dual-enzyme process for high-purity epsilon-caprolactone. Mild conditions, air oxidant, cost-effective supply chain solution for polymer industries.
Patent CN111747910B details a novel gamma-decalactone preparation using 3-hydroxydecanoic acid, offering reduced waste and superior fragrance profiles for flavor manufacturers.